Related Experiment Video

Updated: Jun 11, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?

Luis Ruilope1, Joseph Izzo, Hermann Haller

  • 1Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain. ruilope@ad-hocbox.com

Journal of Clinical Hypertension (Greenwich, Conn.)
|July 2, 2010
PubMed

Insights

Early intervention in diabetes can prevent cardiovascular and kidney disease. Microalbuminuria is a key marker for monitoring disease progression and treatment effectiveness in diabetic patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Diabetology

Background:

  • Cardiovascular disease (CVD) and chronic kidney disease (CKD) are prevalent globally.
  • Diabetes mellitus is a primary cause of premature CVD and CKD.
  • Current research often focuses on patients with existing target organ damage, leaving early intervention effects unclear.

Purpose of the Study:

  • To review evidence supporting microalbuminuria as a disease marker in diabetic patients.
  • To discuss recent trials on preventing or delaying microalbuminuria onset.
  • To assess early intervention strategies for diabetic nephropathy and systemic vascular disease.

Main Methods:

  • Literature review of studies on microalbuminuria in diabetic patients.
  • Analysis of evidence linking microalbuminuria to renal and cardiovascular events.
  • Examination of recent intervention trials focused on early disease markers.

Main Results:

  • Microalbuminuria is strongly associated with increased risk of renal and cardiovascular events in diabetes.
  • Early detection and intervention may prevent or delay the onset of diabetic complications.
  • Intervention trials targeting microalbuminuria show promise in managing disease progression.

Conclusions:

  • Microalbuminuria serves as a critical early disease marker in diabetes.
  • Earlier intervention strategies are crucial for preventing diabetic-related CVD and CKD.
  • Further research and trials are needed to optimize early management of diabetic complications.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.